Marijuana Use and its Connection to Mental Health: What Are We Learning?
Marijuana Use and its Connection to Mental Health: What Are We Learning?
Presented By
-
Nora D. Volkow, M.D.More Info
Brought to You By
Dates and Times
-
-In-Person
Location
-
Pacific BWalt Disney World Dolphin Resort
Lake Buena Vista, FL 32830
According to the National Survey on Drug Use and Health, marijuana is one of the most frequently used drugs around the globe and its use is particularly widespread among young people. In 2022, marijuana was the most commonly used illicit drug in the U.S., with 22.0% of people aged 12 or older (or 61.9 million people) using it in the past year. The percentage was highest among young adults aged 18 to 25 (38.2% or 13.3 million people). The amount of THC, the active ingredient in marijuana, has been increasing steadily over the past few decades. For a person who’s new to marijuana use this may mean exposure to higher THC levels with a greater chance of a harmful reaction. Higher THC levels may explain the rise in emergency room visits involving marijuana use we have seen in recent years. Long-term marijuana use has been linked to mental illness symptoms in some people, including temporary hallucinations and/or paranoia; and worsening symptoms in patients with schizophrenia. Marijuana use has also been linked to other mental health problems, such as depression, anxiety, and suicidal thoughts among teens. This presentation will review current epidemiological trends in marijuana use, the short and long-term effects cannabinoids have on the brain and body and recent studies that have begun to shed light on populations that may be most at risk for serious negative consequences.
- • Counselor
- • Marriage & Family Therapist
- • Nurses
- • Physicians
- • Social Worker
- • Substance Use Disorder Professionals
At the end of this course, participants will be able to:
-
Explain the widespread use of marijuana and other cannabinoids across the globe.
-
Describe increasing trends in marijuana potency in the U.S. over the past several decades.
-
Describe at least two acute and at least two long-term effects of using marijuana.
-
Summarize studies linking heavy marijuana use to such mental disorders as anxiety, depression and schizophrenia.
-
Baranger, D. A. A., Paul, S. E., Colbert, S. M. C., Karcher, N. R., Johnson, E. C., Hatoum, A. S., & Bogdan, R. (2022). Association of Mental Health Burden With Prenatal Cannabis Exposure From Childhood to Early Adolescence: Longitudinal Findings From the Adolescent Brain Cognitive Development (ABCD) Study. JAMA pediatrics, 176(12), 1261–1265. https://doi.org/10.1001/jamapediatrics.2022.3191
-
Bethlehem, R.A.I., Seidlitz, J., White, S.R. et al. Brain charts for the human lifespan. Nature 604, 525–533 (2022). https://doi.org/10.1038/s41586-022-04554-y
-
Chester, L. A., Valmaggia, L. R., Kempton, M. J., Chesney, E., Oliver, D., Hedges, E. P., Klatsa, E., Stahl, D., van der Gaag, M., de Haan, L., Nelson, B., McGorry, P., Amminger, G. P., Riecher-Rössler, A., Studerus, E., Bressan, R., Barrantes-Vidal, N., Krebs, M. O., Glenthøj, B., Nordentoft, M., … EU-GEI High Risk Study Group (2023). Influence of cannabis use on incidence of psychosis in people at clinical high risk. Psychiatry and clinical neurosciences, 77(9), 469–477. https://doi.org/10.1111/pcn.13555
-
Miech, R. A., Johnston, L. D., Patrick, M.E., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E., (2023). Monitoring the Future national survey results on drug use, 1975–2022: Secondary school students. Monitoring the Future Monograph Series. Ann Arbor, MI: Institute for Social Research, University of Michigan. Available at https://monitoringthefuture.org/results/publications/ monographs/
-
Radhakrishnan, R., Skosnik, P. D., Ranganathan, M., Naganawa, M., Toyonaga, T., Finnema, S., Hillmer, A. T., Esterlis, I., Huang, Y., Nabulsi, N., Carson, R. E., & D'Souza, D. C. (2021). In vivo evidence of lower synaptic vesicle density in schizophrenia. Molecular psychiatry, 26(12), 7690–7698. https://doi.org/10.1038/s41380-021-01184-0
-
Silins, E., Horwood, L. J., Patton, G. C., Fergusson, D. M., Olsson, C. A., Hutchinson, D. M., Spry, E., Toumbourou, J. W., Degenhardt, L., Swift, W., Coffey, C., Tait, R. J., Letcher, P., Copeland, J., Mattick, R. P., & Cannabis Cohorts Research Consortium (2014). Young adult sequelae of adolescent cannabis use: an integrative analysis. The lancet. Psychiatry, 1(4), 286–293. https://doi.org/10.1016/S2215-0366(14)70307-4
-
Young-Wolff, K. C., Tucker, L. Y., Alexeeff, S., Armstrong, M. A., Conway, A., Weisner, C., & Goler, N. (2017). Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016. JAMA, 318(24), 2490–2491. https://doi.org/10.1001/jama.2017.17225
TPN.health has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7267. Programs that do not qualify for NBCC credit are clearly identified. TPN.health is solely responsible for all aspects of the programs.
Trusted Provider Network, LLC is recognized by the New York State Education Department’s State Board for Mental Health Practitioners as an approved provider of continuing education for licensed mental health counselors. #MHC-0220.
TPN.health is a CAMFT-approved continuing education provider, provider #1000101.
Trusted Provider Network, LLC is recognized by the New York State Education Department’s State Board for Mental Health Practitioners as an approved provider of continuing education for licensed marriage and family therapists #MFT-0097.
Trusted Provider Network, LLC is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0654.
TPN.health, #1766, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. TPN.health maintains responsibility for this course. ACE provider approval period: 03/31/2022 – 03/31/2025. Social workers completing this course receive 1.5 General continuing education credits. ASWB ACE Credit is not available in NY and NJ.
This course has been approved by TPN.health, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #198061, TPN.health is responsible for all aspects of the programming.This course has been approved by TPN.health, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #198061, TPN.health is responsible for all aspects of the programing. Counselor Skill Group: Legal, Ethical, and Professional Development
-
Workshop Begins
-
Workshop Ends